164 related articles for article (PubMed ID: 17108128)
1. Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.
Ehrich M; Field JK; Liloglou T; Xinarianos G; Oeth P; Nelson MR; Cantor CR; van den Boom D
Cancer Res; 2006 Nov; 66(22):10911-8. PubMed ID: 17108128
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical clustering of lung cancer cell lines using DNA methylation markers.
Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
4. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
7. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
8. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.
Tsou JA; Shen LY; Siegmund KD; Long TI; Laird PW; Seneviratne CK; Koss MN; Pass HI; Hagen JA; Laird-Offringa IA
Lung Cancer; 2005 Feb; 47(2):193-204. PubMed ID: 15639718
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
van den Berg RM; Snijders PJ; Grünberg K; Kooi C; Spreeuwenberg MD; Meijer CJ; Postmus PE; Smit EF; Steenbergen RD
Lung Cancer; 2011 Jun; 72(3):316-21. PubMed ID: 21067843
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
[TBL] [Abstract][Full Text] [Related]
11. CpG island methylation and expression of tumour-associated genes in lung carcinoma.
Dammann R; Strunnikova M; Schagdarsurengin U; Rastetter M; Papritz M; Hattenhorst UE; Hofmann HS; Silber RE; Burdach S; Hansen G
Eur J Cancer; 2005 May; 41(8):1223-36. PubMed ID: 15911247
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analysis: a powerful new tool for lung cancer diagnosis.
Tsou JA; Hagen JA; Carpenter CL; Laird-Offringa IA
Oncogene; 2002 Aug; 21(35):5450-61. PubMed ID: 12154407
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population.
Kim DS; Cha SI; Lee JH; Lee YM; Choi JE; Kim MJ; Lim JS; Lee EB; Kim CH; Park TI; Jung TH; Park JY
Lung Cancer; 2007 Oct; 58(1):1-6. PubMed ID: 17532092
[TBL] [Abstract][Full Text] [Related]
14. Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLC.
Olaussen KA; Soria JC; Park YW; Kim HJ; Kim SH; Ro JY; André F; Jang SJ
Eur J Cancer; 2005 Sep; 41(14):2112-9. PubMed ID: 16129599
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?
de Fraipont F; Moro-Sibilot D; Michelland S; Brambilla E; Brambilla C; Favrot MC
Lung Cancer; 2005 Nov; 50(2):199-209. PubMed ID: 16043258
[TBL] [Abstract][Full Text] [Related]
17. Methylation profiling in non-small cell lung cancer: clinical implications.
Morán A; Fernández-Marcelo T; Carro J; De Juan C; Pascua I; Head J; Gómez A; Hernando F; Torres AJ; Benito M; Iniesta P
Int J Oncol; 2012 Mar; 40(3):739-46. PubMed ID: 22076605
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer: from single-gene methylation to methylome profiling.
Heller G; Zielinski CC; Zöchbauer-Müller S
Cancer Metastasis Rev; 2010 Mar; 29(1):95-107. PubMed ID: 20099008
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation markers of surfactant proteins in lung cancer.
Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
[TBL] [Abstract][Full Text] [Related]
20. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
